Ultragenyx Q&A – A Conversation with Ultragenyx’s CMO and Global Metabolic Dietitian

A Conversation with Ultragenyx’s Chief Medical Officer, Camille Bedrosian to discuss Insights into Future LC-FAOD Research. Also hear from Ultragenyx’s Global Metabolic Dietitian, Bridget Reineking on How to Use the Newly FDA Approved Medicine.

Date: 07/25/2020
Speaker: Camille Bedrosian & Bridget Reineking
Listen Now: Click Here

Related Articles

Moving Mito Medicine: Reneo Strides Study
Date: 06/04/2021
Speaker: Madhu Davies
Patients as Partners in Drug Development
Date: 02/12/2021
Speaker: Dr. Madhu Davies